• Great Britain
  • Germany
  • France
  • China
  • Souht Korea

Life Sciences

Our life sciences team has gained a deserved reputation for providing clients with a quality service, combining technical expertise with special legal knowledge.

Our team has substantial expertise in relation to inventions in the fields of biotechnology and pharmaceuticals, ranging from large multinational pharma companies to UK-based biotech start-ups, as well as health research centres and hospitals, and university technology transfer departments and their spin-out companies. Our team has significant technical expertise in the areas of pharmaceuticals, vaccines, diagnostics, medical devices, healthcare, biotechnology and chemistry, and we understand the market place, the regulatory requirements, and the commercial importance that a well-managed patent portfolio has in the litigious life sciences industry. In addition to acquiring IP rights, we also provide Freedom-to-Operate and validity advice, formulate patent strategies to minimise risk, provide initial patent landscaping assessments, provide detailed infringement opinions ahead of the closure of commercial contracts, as well as attacking and defending patents to enhance our clients’ commercial position.

  • Inside IP Autumn Winter 2020

  • Venner Shipley’s world leading inflammasome client, Inflazome, acquired by Roche

  • Kymab prevails as the Supreme Court affirms the requirement for sufficient disclosure

  • OBN Digital Event: Maximising Opportunities for Life Sciences Post Brexit

  • G3/19: EBA finds plants produced by essentially biological processes are not patentable

  • Inside IP Spring Summer 2020

  • CRISPR patent appeal dismissed

  • The development of lab-on-chip devices

  • COVID-19 and IP